This inventor holds 2 USPTO granted patents. Top assignee: Oklahoma Medical Research Foundation. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: The Innovative Contributions of Linda F. Thompson
Introduction
Linda F. Thompson is a prominent inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of medical diagnostics, particularly in cancer susceptibility. With a total of 2 patents, her work has the potential to impact the lives of many individuals at risk for cancer.
Latest Patents
Thompson's latest patents include a diagnostic assay for cancer susceptibility and a diagnostic assay for breast cancer susceptibility. The first patent focuses on determining the lifetime probability of a person developing cancer based on an allelic variation found in the 3'UTR of the prohibitin gene. This probability is influenced by the sequence at position 729, specifically whether there is a thymine (T) or a cytosine (C) present. The sequence can be determined using standard techniques, preferably through PCR amplification followed by RFLP analysis.
The second patent addresses breast cancer susceptibility, allowing for the assessment of a woman's lifetime probability of developing breast cancer based on the same allelic variation in the prohibitin gene. This polymorphism at position 729 is also recognized as a susceptibility indicator for hereditary breast cancer in men. Similar to her first patent, the sequence determination can be achieved through PCR amplification and RFLP analysis.
Career Highlights
Linda F. Thompson is affiliated with the Oklahoma Medical Research Foundation, where she conducts her research and develops her innovative diagnostic assays. Her work is crucial in advancing the understanding of genetic factors related to cancer susceptibility.
Collaborations
Thompson collaborates with esteemed colleagues, including Robert T. Dell'Orco and Eldon R. Jupe, who contribute to her research endeavors and enhance the impact of her inventions.
Conclusion
Linda F. Thompson's innovative work in cancer susceptibility diagnostics exemplifies the vital role of inventors in advancing medical science. Her contributions have the potential to change the landscape of cancer risk assessment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile